Serna Bio
PrivateLast Round
Seed
Jan 10, 2022
Total Funding Raised
$625,000
Company Overview
Serna Bio is a biotechnology company that utilizes an AI-enabled drug discovery platform to design small molecules that modulate RNA function for the treatment of challenging diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Serna Bio Comparables
Compare Serna Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ReviR Therapeutics | 87% | |
| Saverna Therapeutics AG | 86% | |
| Atomic AI | 86% | |
Serna Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 10, 2022 | ||||
| Accelerator | Jan 2, 2021 |
Serna Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Backed VC | Seed |
| Lifeforce Capital | Seed |
| Amino Collective | Seed |
| Y Combinator | Seed, Accelerator |
| Axial VC | Seed |
| AME Cloud Ventures | Seed |
| Fifty Years | Seed |
Serna Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Serna Bio's valuation, stock price, and market status.